Pituitary contents of beta-endorphin, dynorphin, substance P, cholecystokinin and somatostatin in rats with streptozotocin-lnduced diabetes

NeuroSignals

Volumn 5, Issue 1, 1996, Pages 44-50

  Tang, Fai ^a   Wong, Rachel P P ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cholecystokinin; Diabetes; Dynorphin; Pituitary; Somatostatin; Substance P; Endorphin

Indexed keywords

BETA ENDORPHIN; CHOLECYSTOKININ; CORTICOSTERONE; DYNORPHIN; GLUCOSE; INSULIN; NEUROPEPTIDE; SOMATOSTATIN; SUBSTANCE P;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG TISSUE LEVEL; GLUCOSE BLOOD LEVEL; HYPOPHYSIS; INSULIN BLOOD LEVEL; INSULIN TREATMENT; MALE; NONHUMAN; PROTEIN LOCALIZATION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BETA-ENDORPHIN; BLOOD GLUCOSE; BODY WEIGHT; CHOLECYSTOKININ; CORTICOSTERONE; DIABETES MELLITUS, EXPERIMENTAL; DYNORPHINS; INSULIN; MALE; NEUROPEPTIDES; PITUITARY GLAND; PITUITARY GLAND, ANTERIOR; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN; SUBSTANCE P;

ANIMALIA;

EID: 0029927874     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000109172     Document Type: Article

References (38)

1. Koopman HS, Pi-Sunycr FX: Large changes in food intake in diabetic rats fed high-fat diets. Brain Res Bull 1986;17:861-871.
2. Bluet-Pajot MT, Durand D, Kordon C: Influence of strcptozotocin-in-duccd diabetes on growth hormone secretion in the rat. Neuroendocrinology 1983;36:306-309.
3. Morlcy JE, Levine AS, Gosnell BA, Krahn DD: Peptides as central regulators of feeding. Brain Res Bull 1985:14:511-519.
4. Patel YC, Srikant CB: Somatostatin mediation of adenohypophysial secretion. Annu Rev Physiol 1986:48: 551-567.
5. Williams G, Steel JH, Cardoso H, Ghatci MA, Lee YC, Gill JS, Burrin JM, Polak JM, Bloom S: Increased hypothalamic neuropeptide Y concentrations in diabetic rat. Diabetes 1988;37:763-772.
6. Patel YC, Bankier DA: Changes in somatostatin concentration in pancreas and other tissues of streptozo-tocin-diabctic rats. Endocrinology 1978;103:523-530.
7. Olchovsky D, Bruno JF, Wood TL, Gelato MC, Leidy JW Jr, Gilbert JM Jr, Berelowitz M: Altered pituitary growth hormone (GH) regulation in streptozotocin-diabctic rats: A combined defect of hypothalamic somatostatin and GH-rclcasing factor. Endocrinology 1990:126:53-61.
8. Tang F: Endocrine control of hypothalamic and pituitary met-cnkcph-alin and P-cndorphin contents. Ncu-roendocrinology 1992;53(suppl 1): 68-76.
9. Coslovsky R, Evans RW, Lecman SE, Braverman LF, Aronin F: The effects of gonadal steroids on the contents of substance P in the rat anterior pituitary. Endocrinology 1984:115:2285-2289.
10. Aronin N, Moreney K, Lceman S, Braverman LE, Coslovsky R: Regulation by thyroid hormone of the concentration of substance P in the rat anterior pituitary. Endocrinology 1984:114:2138-2142.
11. Jones PM, O’Halloran DJ, Ghatci MA, Domin J, Bloom SR: Th; influence of adrenal hormone slatus on neuroendocrine peptides in the rat anterior pituitary gland. J Endocrinol 1990;127:437-444.
12. Dcschepper C, Lotstra F, Vande-sande F, Vanderhaeghen JJ: Cliolc-cyslokinin varies in the posterior pituitary and external median eminence of the rat according to factors affecting vasopressin and oxytocin. Lire Sci 1983;32:2571-2577.
13. Rodriguez MN, Gomez-Pan A, Aril-la E: Decrease in number of somatostatin receptors in rat brain aflcr adrenalectomy: Normalization after glucocorticoid replacement. Eur J Pharmacol 1988;123:1147-1152.
14. Morlcy JE, Elson MJ, Levine AS, Shafer RB: Levels of immunorcac-tive dynorphin in brain and pituitary of hypcrthyroid and hypothyroid rats. Eur J Pharmacol 1982;78: 125-127.
15. Fullerton MJ, Smith AI, Fundci JW: Immunoreactivc dynorphin is regulated by estrogen in the rat anterior pituitary. Ncurocndocrinology 1988:47:1-6.
16. Gibson MJ, Dc Nicola A, Krieger DT: Strcptozotocin-induccd diabetes is associated with reduced immunoreactivc beta-endorphin concentrations in neuroinlcrmcdia’.c pituitary lobe and with disrupted circadian periodicity of plasma corticosterone levels. Ncurocndocrinology 1985;41:64-71.
17. Locatelli V, Petraglia F, Tirloni N, Muller EE: Beta endorphin concentrations in the hypothalamus, pitui-try and plasma of streptozotocin-diabctic rats with and without insulin substitution therapy. Life Sci 1986:38:379-386.
18. Tang F: Changes in metenkephalin and β-endorphin contents in the hypothalamus and the pituitary in diabetic rats: Effects of insulin therapy. Clin Exp Pharmacol Physiol 1989; 16:65-75.
19. Kolia MG, Pierzchala K, Houd AA, Van Loon GR: Effect of diabetes on the level of two forms of mct-cnkcphalin in plasma and peripheral tissues of the rat. Neuropeptides 1992;21:55-63.
20. Tang F, Man SY, Lo YM: T3 reverses the changes in metenkephalin and p-endorphin content in the anterior lobe, but not the neuro-intermediate lobe of the pituitary of rats rendered hypothyroid by PTU treatment. Horm Mctab Res 1988; 20:323-326.
21. Tang F, Man SY: The regional distribution of TRH, leu-enkephalin, mct-cnkcphalin. substance P. somatostatin and cholccystokinin in the rat brain and pituitary. Neuropeptides 1991;19:287-292.
22. Wang ZP, Man SY, Tang F: Age related changes in the content of neuropeptides in the rat brain and pituitary. Neurobiol Aging 1993:14: 529-534.
23. Ghazarossian GE, Chaukin C, Goldstein A: A specific radioimmunoassay for the novel opioid peptide dynorphin. Life Sci 1980;27:25-86.
24. Tang F, Cheung A, Vacca-Galloway LL: Measurement of neuropeptides in the brain and spinal cord of wobbler mouse: A model for motoneuron disease. Brain Res 1990:518: 329-333.
25. Forman LJ, Marguis DE, Stevens R, Adler R, Vasilenko PL: Diabetes induced by strcplozolocin results in a decrease in immunoreactivc beta-endorphin level in the pituitary and hypothalamus of female rats. Diabetes 1985;34:1104-1107.
26. Rossier J, French E, Gros C, Minick S, Guillemin R, Bloom FE: Adrenalectomy, dcxamelhasone or stress alters opioid peptides levels in rat anterior pituitary but not intermediate lobe or brain. Life Sci 1979:25: 2105-2112.
27. Rhees RW, Wilson CT, Heninger RW: Influence of streptozotocin diabetes and insulin therapy on plasma corticosterone level in male rats. Horm Metab Res 1983; 15:353-354.
28. Knepel W, Schwaninger M: Release of dynorphin-likc immunorcactivity from rat anterior pituitary gland in vitro. Naunyn Schmicdcbcrgs Arch Pharmacol 1985;329:94-96.
29. Yagev L, Goltricch A, Timan B, Ho-monnai ZT, Paz GF: Changes in LH and prolactin levels in diabetic male rats and the role of the opiate system in the control of their secretion. Life Sci 1985;37:993-999.
30. Ferguson-Segall M, Flynn JJ, Walker J, MargulcsDL: Increased immunoreactivc dynorphin and lcu-cn-kcphalin in posterior pituitary of obese mice (ob/ob) and supcrscnsi-tivity to drugs that act on kappa receptors. Life Sci 1982:31:2233-2236.
31. Goldstein A: Biology and chemistry of the dynorphin peptides; in Uden-friend S, Mcicnhofer J (eds): The Peptides. New York, Academic Press, 1984, pp 96-141.
32. Beinfield MC, Meyer DK, Brown-Stein MJ: Cholccystokinin octapcp-tidc in the rat hypothalamico-ncuro-hypophysial system. Nature 1980; 288:376-378.
33. Brooks DP, Nutting DF, Crofton JT, Share L: Vasopressin in rats with genetic and strcptozotocin-induced diabetes. Diabetes 1989;38:54-57.
34. McKibbin P, McCarthy HD, Shaw P, Williams G: Insulin deficiency is a specific stimulus to hypothalamic neuropeptide Y: A comparison of the effects of insulin replacement and food restriction in stcptozoto-cin-diabctic rats. Peptides 1992; 13: 721-727.
35. Hoill V, Haarmann I, Scizinger ER, Herz A: Levels of dynorphin (1-13) immunorcactivity in rat neurointer-mcdiate pituitarics arc concomitantly altered with those of leucine enkephalin and vasopressin in response to various endocrine manipulations. Ncurocndocrinology 1981; 33:333-339.
36. Green IC, Ray K, Perrin D: Opioid effect on insulin release and c-AMP in islets of Langcrhans. Horm Metab Res 1983:15:124-128.
37. Sakamoto C, Otsuki M, Ohki A, Yuu H, Maeda M, Yamasaki T, Baba S: Glucosc-dcpcndcnt insuli-notropic action of cholccystokinin and cacrulin in the isolated perfused rat pancreas. Endocrinology 1982; 110:398-402.
38. Pettibone DJ, Mueller GP: Adrenergic control of immunoreactivc ß-endorphin release from the pituitary of the rat: In vitro and in vivo studies. J Pharmacol Exp Titer 1982; 222:103-108.